Volume 7, Issue 2 (5-2019)                   Iran J Health Sci 2019, 7(2): 1-8 | Back to browse issues page


XML Print


Zahedan University of Medical Sciences, Zahedan, Iran , ansarih88@gmail.com
Abstract:   (461 Views)
Background and purpose: Breast cancer is one of the most common cancers in women all over the world. The death rate of this cancer is also increasing. It seems that medication is related to this cancer. The present study aimed at estimating the risk of this cancer using Gail Model and its relationship with medication in women.
Materials and Methods: In this cross-sectional study, 260 35-year-old women and more were selected from healthcare centers in Zahedan. The data were collected using interview and questionnaire. The risk of breast cancer was estimated by Gail Model. The medication conditions were estimated by interviewing the employees in healthcare center. The data were analyzed using independent sample t-test and linear regression.
Results: The average age of women was 49.3±8.3 years old with five-year risk, and the life time of breast cancer were 0.37±0.24 and 5.5±0.79 percent, respectively. Self-medication (P=0.043) and medication (p=0.035) had a significant relationship with estimated risk of breast cancer.
Conclusion: The risk of breast cancer in women can be influenced by medication along with socioeconomic and menstrual-reproductive factors and variables, such as ethnicity, body mass index, education, age, marriage age, nursing period, and menstrual age. The final analysis showed that consuming contraceptive pills, painkillers, and anti-inflammatory pills are the most important predictive factors in 5-year risk with cancer based on Gail Model. On the other hand, consuming painkillers and contraceptive pills were found to be the most important predictive factors in lifetime risk with cancer based on Gail Model.
 
Full-Text [PDF 436 kb]   (107 Downloads)    

References
1. Heydari ST, Mehrabani D, Tabei SZ, Azarpira N, Vakili MA. Survival of breast cancer in southern Iran. Iranian Journal of Cancer Prevention. 2009; 2(1):51-4.
2. United Cancer Statistics Working Group. United States Cancer Statistics: 1999-2010 Incidence and Mortality Web-based Report. Atlanta, GA: Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2014.
3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. Cancer Journal of Clinicians.2018; 68(1): 7-30. Epub 2018 Jan 4. [DOI:10.3322/caac.21442] [PMID]
4. Lotfi M, Charkhatti S, Shobairi S. Breast cancer risk factor in an urban area of Yazd city-Iran 2006. Acta Medica Iranica. 2008; 46(3): 258-64.
5. Montazeri A, Vahdaninia M, Harirchi I, Harirchi AM, Sajadian A, Khaleghi F, et al. Breast cancer in Iran: Need for greater women awareness of warning signs and effective screening methods. Asian Pacific Family Medicine. 2008; 7(1):6. [DOI:10.1186/1447-056X-7-6] [PMID] [PMCID]
6. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Annual Oncology. 2009; 20(3): 556-663. [DOI:10.1093/annonc/mdn642] [PMID]
7. Babu GR1, Samari G, Cohen SP, Mahapatra T, Wahbe RM, Mermash S, Galal OM. Breast cancer screening among females in Iran and recommendations for improved practice: a review. Asian Pacific Journal of Cancer Prevention.2011; 12(7):1647-55.
8. Ozmen V, Ozcinar B, Karanlik H, Cabioglu N, Tukenmez M, Disci R et al. Breast cancer risk factors in Turkish women-a University Hospital based nested case control study. World Journal of Surgical Oncology. 2009; 7(4): 37-43. [DOI:10.1186/1477-7819-7-37] [PMID] [PMCID]
9. Soroush A, Farshchian N, Komasi S, Izadi N, Amirifard N, Shahmohammadi A. The Role of Oral Contraceptive Pills on Increased Risk of Breast Cancer in Iranian Populations: A Meta-analysis. Journal of Cancer Prevention. 2016; 21(4):294-301. [DOI:10.15430/JCP.2016.21.4.294] [PMID] [PMCID]
10. Tazhibi M, Dehghani M, Babazadeh S, Makkarian F, Tabatabaeian M, Sadeghi M, Rezaei P, Faghihi M. Hormonal and reproductive risk factors associated with breast cancer in Isfahan patients. Journal of Education and Health Promotion. 2014;3(9):3-69.
11. Cairat M, Fournier A, Murphy N, Biessy C, Scalbert A, Rinaldi S et al. Nonsteroidal anti-inflammatory drug use and breast cancer risk in a European prospective cohort study. International Journal of Cancer.2018; [Epub ahead of print]. [DOI:10.1002/ijc.31570] [PMID]
12. AlFaris NA, ALkehayez NM, AlMushawah FI, Al Naeem AN, Al-Amri ND, Almudawah ES. A descriptive study of vitamin D and other nutritional factors in breast cancer patients in Saudi Arabia. Saudi Medical Journal. 2018; 39(6): 564-571. [DOI:10.15537/smj.2018.6.21902] [PMID] [PMCID]
13. Rohan TE, Negassa A, Chlebowski RT, Ceria-Ulep CD, Cochrane BB, Lane DS et al. A randomized controlled trial of calcium plus vitamin D supplementation and risk of benign proliferative breast disease. Breast Cancer Research Treatment. 2009; 116(2): 339-50. [DOI:10.1007/s10549-008-0213-0] [PMID] [PMCID]
14. Taghavi A, Fazeli Z, Vahedi M, Baghestani AR, Pourhoseingholi A,Barzegar F, et al. Increased trend of breast cancer mortality in Iran. Asian Paciofic Journal of Cancer Prevention. 2012;13(2):367-70. [DOI:10.7314/APJCP.2012.13.1.367] [PMID]
15. Gail MH, Costantino JP, Pee D, Bondy M, Newman L, Selvan M, et al. Projecting individualized absolute invasive breast cancer risk in African American women. Journal of National Cancer Institue. 2007; 99(23): 1782-92. [DOI:10.1093/jnci/djm223] [PMID]
16. Mousavi SM, Montazeri A, Mohagheghi MA, Jarrahi AM, Harirchi I,Najafi M, et al. Breast cancer in Iran: An epidemiological review. Breast Journal. 2007; 13(2): 383-91. [DOI:10.1111/j.1524-4741.2007.00446.x] [PMID]
17. Etemadi A, Sadjadi A, Semnani S, Nouraie SM, Khademi H,Bahadori M. Cancer registry in Iran: A brief overview. Archives of Iranian Medicine. 2008; 11(6):577-80.
18. Mohammadbeigi A, Mohammadsalehi N, ValizadehR, Momtaheni Z, Mokhtari M, Ansari H. Lifetime and 5 years risk of breast cancer and attributable risk factor according to Gail model in Iranian women. Journal of Pharmacy and Bioallied Sciences. 2015;7(5):207-11. [DOI:10.4103/0975-7406.160020] [PMID] [PMCID]
19. Decarli A, Calza S, Masala G, Specchia C, Palli D, Gail MH. Gail model for prediction of absolute risk of invasive breast cancer: Independent evaluation in the Florence-European Prospective Investigation into Cancer and Nutrition cohort. Journal of National Cancer Institue.2006; 98(22): 1686-93. [DOI:10.1093/jnci/djj463] [PMID]
20. Arrospide A, Forné C, Rué M, Torà N, Mar J, Baré M. An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain. BMC Cancer. 2013, 13:587. [DOI:10.1186/1471-2407-13-587] [PMID] [PMCID]
21. Lotfi MH, Yavari P, Falahzadeh H, Shiryazdi SM, Zahedi A. Relation between Socioeconomic and Fertility Factors with Breast Cancer: Case - control Study. The Journal of Toloo-e-behdasht. 2016; 14(6): 356-371. [In Persian]